Applications
This invention presents monoclonal antibodies against FcRII, and the antibody-producing hybridoma cell line. These antibodies can be utilized in evaluation of function and regulation of FcRII.
Advantages
This inventions presents the first monoclonal antibody that recognize FcRII, and provides a novel tool in FcRII related research.